Figure 3.

Myricetin inhibits the migratory capacity of ovarian cancer cells, as determined using a Boyden Chamber assay. The extent of migration was determined by staining the Boyden Chambers with crystal violet and measuring the absorbance at a wavelength of 600 nm. (A) The effect of myricetin on the migration of A2780 cells. (B) The effect of myricetin on OVCAR3 cells. The results are presented as the mean ± standard deviation of three independent experiments. *P<0.05, control vs. myricetin-treated cells.